High Court Won't Hear Pfizer Shareholder Suit
The U.S. Supreme Court on Monday declined to hear an appeal from Pfizer Inc. challenging the timeliness of a securities fraud class action accusing the drugmaker of misrepresenting studies of arthritis...To view the full article, register now.
Already a subscriber? Click here to view full article